Spencer Emtage

3.0k total citations
16 papers, 1.4k citations indexed

About

Spencer Emtage is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Spencer Emtage has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology and Allergy. Recurrent topics in Spencer Emtage's work include Cystic Fibrosis Research Advances (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Spencer Emtage is often cited by papers focused on Cystic Fibrosis Research Advances (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (2 papers). Spencer Emtage collaborates with scholars based in United States, United Kingdom and Spain. Spencer Emtage's co-authors include Richard D. Palmiter, Eileen R. Mulvihill, Pamela B. Moore, J.M. Sauder, Robert A. Hallewell, J.F. Hunt, Xun Zhao, T. Gheyi, William B. Guggino and K. Conners and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Spencer Emtage

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Spencer Emtage United States	15	925	386	226	133	120	16	1.4k
Gerd Zettlmeißl Germany	20	823 0.9×	188 0.5×	169 0.7×	183 1.4×	51 0.4×	33	1.3k
Guang‐Jer Wu United States	23	865 0.9×	112 0.3×	206 0.9×	109 0.8×	262 2.2×	48	1.3k
James P. Koch United States	13	659 0.7×	167 0.4×	151 0.7×	111 0.8×	281 2.3×	19	1.1k
Andrew P. VanDemark United States	23	1.7k 1.8×	148 0.4×	100 0.4×	101 0.8×	188 1.6×	42	2.0k
Nishit K. Mukhopadhyay United States	22	1.0k 1.1×	196 0.5×	100 0.4×	114 0.9×	200 1.7×	42	1.4k
Kenta Masuda Japan	25	896 1.0×	98 0.3×	236 1.0×	141 1.1×	278 2.3×	77	1.7k
Ling Yao China	23	883 1.0×	148 0.4×	200 0.9×	91 0.7×	231 1.9×	104	1.4k
Remco A. Spanjaard United States	24	1.3k 1.4×	77 0.2×	387 1.7×	228 1.7×	278 2.3×	48	1.7k
N. Yu. Oparina Russia	19	804 0.9×	82 0.2×	174 0.8×	84 0.6×	105 0.9×	53	1.1k
Mitsumasa Hashimoto Japan	20	1.5k 1.6×	136 0.4×	186 0.8×	70 0.5×	510 4.3×	60	2.0k

Countries citing papers authored by Spencer Emtage

Since Specialization

Citations

This map shows the geographic impact of Spencer Emtage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spencer Emtage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spencer Emtage more than expected).

Fields of papers citing papers by Spencer Emtage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spencer Emtage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spencer Emtage. The network helps show where Spencer Emtage may publish in the future.

Co-authorship network of co-authors of Spencer Emtage

This figure shows the co-authorship network connecting the top 25 collaborators of Spencer Emtage. A scholar is included among the top collaborators of Spencer Emtage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spencer Emtage. Spencer Emtage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Antonysamy, Stephen, Zahid Bonday, Robert M. Campbell, et al.. (2012). Crystal structure of the human PRMT5:MEP50 complex. Proceedings of the National Academy of Sciences. 109(44). 17960–17965. 256 indexed citations

Kamat, Siddhesh S., Gregory P. Holmes‐Hampton, Ashima Bagaria, et al.. (2011). The catalase activity of diiron adenine deaminase. Protein Science. 20(12). 2080–2094. 10 indexed citations

Foreman, Kenneth W., Mark A. Brown, Spencer Emtage, et al.. (2011). Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3. PLoS ONE. 6(7). e22290–e22290. 89 indexed citations

Protasevich, Irina I., Zhengrong Yang, S. Atwell, et al.. (2010). Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide‐binding domain 1. Protein Science. 19(10). 1917–1931. 102 indexed citations

Kikani, Chintan K., J.B. Bonanno, Marijane Russell, et al.. (2010). Structural Bases of PAS Domain-regulated Kinase (PASK) Activation in the Absence of Activation Loop Phosphorylation. Journal of Biological Chemistry. 285(52). 41034–41043. 26 indexed citations

Atwell, S., Christie G. Brouillette, K. Conners, et al.. (2010). Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant. Protein Engineering Design and Selection. 23(5). 375–384. 83 indexed citations

Rutter, M., K.T. Bain, Isabelle Rooney, et al.. (2008). High Throughput Protein Production and Crystallization at NYSGXRC. Methods in molecular biology. 426. 561–575. 30 indexed citations

Lewis, H.A., Xun Zhao, Chi Chiu Wang, et al.. (2004). Impact of the ΔF508 Mutation in First Nucleotide-binding Domain of Human Cystic Fibrosis Transmembrane Conductance Regulator on Domain Folding and Structure. Journal of Biological Chemistry. 280(2). 1346–1353. 228 indexed citations

Tugores, Antonio, Jennifer Lê, Irina Sorokina, et al.. (2001). The Epithelium-specific ETS Protein EHF/ESE-3 Is a Context-dependent Transcriptional Repressor Downstream of MAPK Signaling Cascades. Journal of Biological Chemistry. 276(23). 20397–20406. 65 indexed citations

10.

Emtage, Spencer, et al.. (1997). Pulmonary biology of anti-interleukin 5 antibodies. Memórias do Instituto Oswaldo Cruz. 92(suppl 2). 69–73. 21 indexed citations

11.

Lewthwaite, J, Simon Blake, Tim Hardingham, et al.. (1995). Role of TNF alpha in the induction of antigen induced arthritis in the rabbit and the anti-arthritic effect of species specific TNF alpha neutralising monoclonal antibodies.. Annals of the Rheumatic Diseases. 54(5). 366–374. 21 indexed citations

12.

Egan, Robert W., Chuan‐Chu Chou, Spencer Emtage, et al.. (1995). Inhibition of Pulmonary Eosinophilia and Hyperreactivity by Antibodies to lnterleukin-5. International Archives of Allergy and Immunology. 107(1-3). 321–322. 58 indexed citations

13.

Stephens, Sue, Spencer Emtage, L Chaplin, et al.. (1995). Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses.. PubMed. 85(4). 668–74. 99 indexed citations

14.

Tacon, William C., N. H. Carey, & Spencer Emtage. (1980). The construction and characterisation of plasmid vectors suitable for the expression of all DNA phases under the control of the E. coli tryptophan promoter. Molecular and General Genetics MGG. 177(3). 427–438. 49 indexed citations

15.

Hallewell, Robert A. & Spencer Emtage. (1980). Plasmid vectors containing the tryptophan operon promoter suitable for efficient regulated expression of foreign genes. Gene. 9(1-2). 27–47. 66 indexed citations

16.

Palmiter, Richard D., Pamela B. Moore, Eileen R. Mulvihill, & Spencer Emtage. (1976). A significant lag in the induction of ovalbumin messenger RNA by steroid hormones: A receptor translocation hypothesis. Cell. 8(4). 557–572. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact